India

Shearman, Davis Polk on $3.2 Billion India Drug Merger

, The Asian Lawyer

   | 0 Comments

Indian generic drug maker Sun Pharmaceutical Industries Ltd. is acquiring local competitor Ranbaxy Laboratories Ltd. from Japan's Daiichi Sankyo Co.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202650142708

Thank you!

This article's comments will be reviewed.